From: Continuous glucose monitors prove highly accurate in critically ill children
Category | N | Glucose comparisons | Age (yr) | Weight (kg) | % Female (N) | Ethnicity (N) | ICU LOS (days) | % CIH (N) | CGMdays | Pearson's correlation coefficient |
---|---|---|---|---|---|---|---|---|---|---|
All | 47 | 1555 | 4.3 (0.01 to 16) | 20.6 (2.4 to 87) | 34% (16) | AA 1.1% (24) H 8.5% (4) C 36.2% (17) | 15 (2 to 102) | 79% (34) | 6.1 (1 to 18) | .68 |
A. Primary diagnosis | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Medical | 29 | 895 | 4.6 (0.1 to 14) | 22.5 (2.9 to 87) | 41.4% (12) | AA 51.7% (15) H 10.3% (3) C 31% (9) | 13.4 (2 to 41) | 66% (19) | 6.2 (1 to 15) | .71 |
Cardiac surgery | 10 | 222 | 1.2 (0.01 to 7) | 7.5 (2.4 to 20.2) | 40% (4) | AA 30% (3) H 10% (1) C 60% (6) | 11 (2 to 44) | 70% (7) | 3.2 (1 to 7) | .81 |
Surgery/other | 8 | 438 | 7.1 (1.9 to 16) | 30.2 (12.7 to 59) | 0% (0) | AA 75% (6) H 0% (0) C 25% [39] | 25.6 (4 to 102) | 100% (8) | 9.4 (1 to 18) | .50 |
TBI/ICH | 6 | 113 | 5.3 (0.1 to 14) | 21.4 (3.3 to 50) | 16.7% (1) | AA 33.3% [39] H 0% (0) C 66.7% (4) | 10.2 (6 to 15) | 14% [39] | 5.5 (2 to 14) | .59 |
B. Support | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
VPI/Inotropes | 30 | 1184 | 4.4 (0.01 to 16) | 19 (2.4 to 87) | 43.3% (13) | AA 50% (15) H 10% (3) C 33.3% (10) | 17.6 (2 to 102) | 80% (24) | 6.5 (1 to 18) | .73 |
IV Steroids | 32 | 1321 | 4 (0.01 to 16) | 20 (2.4 to 87) | 31.3% (10) | AA 65.6% (21) H 6.3% [39] C 25% (8) | 17.4 (2 to 102) | 81% (26) | 6.6 (1 to 18) | .69 |
CVVH | 6 | 495 | 6.8 (1.3 to 16) | 34.7 (8 to 87) | 50% (3) | AA 83.3% (5) H 0% (0) C 16.7% (1) | 34.5 (12 to 102) | 83% (5) | 10.3 (4 to 18) | .76 |
ECMO | 3 | 216 | 5.8 (1.3 to 16) | 39.7 (10 to 87) | 33.3% (1) | AA 66.7% [39] H 0% (0) C 33.3% (1) | 25 (12 to 38) | 100% (3) | 12 (8 to 18) | .57 |
C. CIH | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
No | 13 | 96 | 2 (0.04 to 9) | 12.8 (2.4 to 55) | 30.8% (4) | AA 53.8% (7) H 23.1% (3) C 23.1% (3) | 10.1 (2 to 25) | 0% (0) | 3.3 (1 to 7) | .68 |
Yes - without insulin therapy | 14 | 324 | 1.7 (0.01 to 14) | 12.2 (2.9 to 74) | 35.7% (5) | AA 35.7% (5) H 0% (0) C 50% (7) | 14.5 (2 to 41) | 100% (14) | 6.1 (1 to 13) | .71 |
Yes - with insulin therapy | 20 | 1135 | 7.5 (0.01 to 16) | 31.7 (3.5 to 87) | 35% (7) | AA 60% (12) H 5% (1) C 35% (7) | 18.6 (2 to 102) | 100% (20) | 7.9 (1 to 18) | .67 |
D. Age | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Less than one years | 18 | 374 | 0.3 (0.01 to 0.8) | 5.3 (2.4 to 9.2) | 38.9% (7) | AA 38.9% (7) H 11.1% [39] C 44.4% (8) | 15.4 (2 to 44) | 56% (10) | 5.3 (1 to 12) | .75 |
One to five years | 13 | 416 | 2.3 (1.2 to 4) | 13.7 (10 to 20) | 23.1% (3) | AA 61.5% (8) H 7.7% (1) C 23.1% (3) | 10.3 (2 to 33) | 77% (10) | 5.5 (1 to 13) | .64 |
6 to 10 years | 9 | 488 | 7.6 (6 to 10) | 34.9 (20.2 to 87) | 44.4% (4) | AA 55.6% (5) H 11.1% (1) C 33.3% (3) | 15.2 (2 to 38) | 78% (7) | 8 (1 to 18) | .73 |
More than 10 years | 7 | 277 | 14 (13 to 16) | 54.6 (32.4 to 74) | 28.6% [39] | AA 57.1% (4) H 0% (0) C 42.9% (3) | 22.4 (2 to 102) | 100% (7) | 6.7 (1 to 14) | .55 |
E. PELOD | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
<12 | 30 | 604 | 4.1 (0.01 to 14) | 20.3 (2.4 to 74) | 30% (30) | AA 46.7% (14) H 13.3% (4) C 33.3% (10) | 11.8 (2 to 41) | 63% (19) | 4.9 (1 to 18) | .69 |
≥12 | 17 | 951 | 4.6 (0.01 to 16) | 21.3 (3.3 to 87) | 41.2% (7) | AA 58.8% (10) H 0% (0) C 41.2% (7) | 20.6 (3 to 102) | 88% (15) | 8.2 (1 to 15) | .68 |
F. ICU LOS | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Less than three days | 5 | 45 | 5 (0.2 to 14) | 25.2 (6.2 to 74) | 41.2% (7) | AA 60% (3) H 20% (1) C 20% (1) | 2 (2 to 2) | 60% (3) | 1.4 (1 to 2) | .74 |
Three to seven days | 12 | 139 | 3.8 (0.1 to 14) | 17.9 (3.3 to 67.8) | 8.3% (1) | AA 33.3% (4) H 16.7% [39] C 41.7% (5) | 5 (3 to 7) | 58% (7) | 2.2 (1 to 5) | .85 |
More than seven days | 30 | 1371 | 4.3 (0.01 to 16) | 21 (2.4 to 87) | 43.3% (13) | AA 56.7% (17) H 3.3% (1) C 36.7% (11) | 21.2 (8 to 102) | 80% (24) | 8.4 (2 to 18) | .66 |